| 靶点: |
IC50: 0.54 µM (AC1) |
| 体内研究: |
AC1-IN-1 (5.6 mg/kg; i.v.) displays modest, yet statistically significant, antiallodynic effects at 1 h post-treatment compared to the 0 min (allodynic) time point. |
| 参考文献: |
1. Scott JA, et al. Optimization of a Pyrimidinone Series for Selective Inhibition of Ca2+/Calmodulin-Stimulated Adenylyl Cyclase 1 Activity for the Treatment of Chronic Pain. J Med Chem. 2022; 65(6):4667-4686. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.814 ml |
14.07 ml |
28.14 ml |
| 5 mM |
0.563 ml |
2.814 ml |
5.628 ml |
| 10 mM |
0.281 ml |
1.407 ml |
2.814 ml |
| 50 mM |
0.056 ml |
0.281 ml |
0.563 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |